Additional Listing

RNS Number : 8002F

Dechra Pharmaceuticals PLC

16 November 2015

 



16 November 2015

Dechra^® Pharmaceuticals PLC

(Dechra or the Company) 

Additional Listing

An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 70,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List.

These Shares are being reserved under a block listing and will be issued pursuant to the following scheme:

Scheme	Shares
SAYE Scheme	70,000

These Shares will rank pari passu with the Company's existing shares in issue.  It is expected that admission will become effective on 20 November 2015. 

For further information

Suzana Cross, General Counsel and Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

LISLIFLALILRLIE